RCSB PDB - 5C3T: PD-1 binding domain from human PD-L1 (original) (raw)
Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1.
[Zak, K.M.](/search?q=citation.rcsb%5Fauthors:Zak, K.M.), [Kitel, R.](/search?q=citation.rcsb%5Fauthors:Kitel, R.), [Przetocka, S.](/search?q=citation.rcsb%5Fauthors:Przetocka, S.), [Golik, P.](/search?q=citation.rcsb%5Fauthors:Golik, P.), [Guzik, K.](/search?q=citation.rcsb%5Fauthors:Guzik, K.), [Musielak, B.](/search?q=citation.rcsb%5Fauthors:Musielak, B.), [Domling, A.](/search?q=citation.rcsb%5Fauthors:Domling, A.), [Dubin, G.](/search?q=citation.rcsb%5Fauthors:Dubin, G.), [Holak, T.A.](/search?q=citation.rcsb%5Fauthors:Holak, T.A.)
(2015) Structure 23: 2341-2348
PubMed Abstract:
Targeting the PD-1/PD-L1 immunologic checkpoint with monoclonal antibodies has recently provided breakthrough progress in the treatment of melanoma, non-small cell lung cancer, and other types of cancer. Small-molecule drugs interfering with this pathway are highly awaited, but their development is hindered by insufficient structural information. This study reveals the molecular details of the human PD-1/PD-L1 interaction based on an X-ray structure of the complex. First, it is shown that the ligand binding to human PD-1 is associated with significant plasticity within the receptor. Second, a detailed molecular map of the interaction surface is provided, allowing definition of the regions within both interacting partners that may likely be targeted by small molecules.
Organizational Affiliation:
Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland; Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387 Krakow, Poland.
Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387 Krakow, Poland; Department of Organic Chemistry, Jagiellonian University, Ingardena 3, 30-060 Krakow, Poland.
Department of Organic Chemistry, Jagiellonian University, Ingardena 3, 30-060 Krakow, Poland.
Department for Drug Design, University of Groningen, A. Deusinglaan 9, 9713 AV Groningen, the Netherlands.
Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland; Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387 Krakow, Poland. Electronic address: grzegorz.dubin@uj.edu.pl.
Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387 Krakow, Poland; Department of Organic Chemistry, Jagiellonian University, Ingardena 3, 30-060 Krakow, Poland; Max Planck Institute for Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany. Electronic address: holak@chemia.uj.edu.pl.